Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali
New Delhi, Feb 19: Yoga guru Baba Ramdev's Patanjali Ayurved on Friday said its Coronil tablet has received certification from the Ayush Ministry as a medicine supporting COVID-19 treatment as per the World Health Organization's certification scheme.
Patanjali also released what it claimed was research work supporting Coronil's efficacy in COVID-19 treatment.
The Union Ayush Ministry had earlier categorised ayurvedic Coronil tablets as an ''Immuno-booster''.
Now, it has been recognised as a medicine for "supporting measure in COVID-19" treatment, Ramdev told reporters at a press conference here.
"Study on the impact of Coronil on COVID has already been published in leading journals," Ramdev said, adding "it would work not only for treatment, prevention and cure of COVID but also help in after-effects."
This is the first company in India which has received such a licence, he claimed.
The announcement regarding the Ayush certification for Coronil and release of a research paper calling it the "first evidence-based medicine for COVID-19 by Patanjali" was done at an event here attended by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.
In a statement, Patanjali said: "Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme."
Under CoPP, Coronil can now be exported to 158 countries, it claimed.
Patanjali had introduced ayurveda-based Coronil on June 23 last year, when the pandemic was at its peak. It had to face severe criticism as it lacked scientific evidence regarding its efficacy.
The Ayush Ministry had classified it as an "Immuno-booster" only.
The ministry earlier this month recognised Coronil as a medicine for "supporting measure in COVID-19" treatment, Ramdev said.
"This certification will remove the misconception about it in people''s mind as it cures COVID also," Ramdev said, adding "it will work against asymptomatic, symptomatic and severe (cases) also. We have data for that."
"It received a huge response despite all controversies. We have data which suggests that more than one crore people have consumed it," he added.
Ramdev further said Coronil will help humanity while providing sustainable and affordable treatment.
"Some people manufacture medicines for their business but we have done it for treatment and welfare of the public (upchar aur upkar ke bhavna se)," he said.
After Coronil, Patanjali now plans to introduce more ayurvedic medicines, backed with scientific evidence and certification, he added.
Patanjali spokesperson S K Tijarawala said Coronil has done business of Rs 500 crore in the last seven months.
Coronil has been developed by Patanjali Research Institute. It had started work on an ayurvedic remedy for COVID-19 in January 2020.
We are delighted and proud to state that Coronil has been granted a CoPP license by DCGI, in accordance with the WHO GMP quality approvals. pic.twitter.com/4wT0TEbrV2
— Acharya Balkrishna (@Ach_Balkrishna) February 19, 2021
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Apr 20: Karnataka reports biggest single day spike of 21,794 COVID cases, 149 deaths
Bengaluru, Apr 20: Karnataka has reported its biggest single day spike of 21,794 COVID-19 cases and 149 related fatalities, taking the total caseload 11.98 lakh and the toll to 13,646, the Health department said on Tuesday.
The state had previously reported its biggest single day spike of 19,067 cases on Sunday.
Out of the 21,794 fresh cases reported on Tuesday, 13,782 were from Bengaluru Urban alone.
The day also saw 4,571 patients getting discharged after recovery.
Cumulatively 11,98,644 COVID-19 positive cases have been confirmed in the state, which includes 13,646 deaths and 10,25,821 discharges,the Health department said in a bulletin.
Out of 1,59,158 active cases, 1,58,407 patients are stable and in isolation at designated hospitals, while 751 are in Intensive Care Units.
Among 149 deaths reported on Tuesday, 92 were from Bengaluru Urban, Bengaluru Rural (13), Bidar and Kalaburagi (7), Ballari (5), followed by others.
Among the districts where the new cases were reported, Bengaluru Urban accounted for 13,782, Tumakuru 1,055, Kalaburagi 818, Mysuru 699, Bengaluru Rural 513, Dakshina Kannada 482, followed by others.
Bengaluru Urban district topped the list of positive cases, with a total of 5,70,035, followed by Mysuru 63,018 and Ballari 42,745.
Among discharges too, Bengaluru Urban was on top with 4,49,889, followed by Mysuru 57,745 and Ballari 39,829.
A total of over 2,38,64,354 samples have been tested so far, out of which 1,47,488 were done on Tuesday alone.
To view today's health bulletin: CLICK HERE
Today's Media Bulletin 20/04/2021
— K'taka Health Dept (@DHFWKA) April 20, 2021
Please click on the link below to view bulletinhttps://t.co/MLAECigCjA@mla_sudhakar @DVSadanandGowda @ShobhaBJP @PCMohanMP @Tejasvi_Surya @CTRavi_BJP @kiranshaw @WFRising @citizenkamran @BangaloreBuzz @RCBTweets @NammaKarnataka_ pic.twitter.com/NHay6R6Rr9
